MX2009014102A - Sistema de administración transdérmica que comprende glicopirrolato para tratar sialorrea. - Google Patents
Sistema de administración transdérmica que comprende glicopirrolato para tratar sialorrea.Info
- Publication number
- MX2009014102A MX2009014102A MX2009014102A MX2009014102A MX2009014102A MX 2009014102 A MX2009014102 A MX 2009014102A MX 2009014102 A MX2009014102 A MX 2009014102A MX 2009014102 A MX2009014102 A MX 2009014102A MX 2009014102 A MX2009014102 A MX 2009014102A
- Authority
- MX
- Mexico
- Prior art keywords
- patch
- sialorrhea
- transdermal
- glycopyrrolate
- delivery system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
En un aspecto, la invención incluye un método para tratamiento de la sialorrea, que comprende las pasos de identificar un paciente que padece de sialorrea y administrar una cantidad terapéuticamente efectiva de glicopirrolato al paciente empleando una ruta de de administración transdérmica En otro aspecto, la invención es un sistema de administración de fármaco transdérmica para tratar a un paciente que muestra sialorrea, incluyendo un parche transdérmico, una cantidad terapéuticamente efectiva de glicopirrolato contenida en el parche transdérmico para aliviar la sialorrea, y un portador farmacéuticamente aceptable. El parche transdérmico puede ser un parche monocapa de adhesivo con fármaco, un parche de múlticapa de adhesivo con un fármaco o un parche de tipo reservorio.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94575807P | 2007-06-22 | 2007-06-22 | |
PCT/US2008/067908 WO2009002935A1 (en) | 2007-06-22 | 2008-06-23 | Transdermal delivery system comprising glycopyrrolate to treat sialorrhea |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009014102A true MX2009014102A (es) | 2010-03-09 |
Family
ID=39719145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009014102A MX2009014102A (es) | 2007-06-22 | 2008-06-23 | Sistema de administración transdérmica que comprende glicopirrolato para tratar sialorrea. |
Country Status (6)
Country | Link |
---|---|
US (1) | US20080317832A1 (es) |
EP (1) | EP2170305A1 (es) |
JP (1) | JP2010530902A (es) |
AU (1) | AU2008268465A1 (es) |
MX (1) | MX2009014102A (es) |
WO (1) | WO2009002935A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014123977A1 (en) * | 2013-02-06 | 2014-08-14 | Rohto Usa, Inc. | Geranylgeranylacetone formulations |
US9006462B2 (en) | 2013-02-28 | 2015-04-14 | Dermira, Inc. | Glycopyrrolate salts |
US8558008B2 (en) | 2013-02-28 | 2013-10-15 | Dermira, Inc. | Crystalline glycopyrrolate tosylate |
JP6114841B2 (ja) | 2013-02-28 | 2017-04-12 | ダーミラ, インク.Dermira, Inc. | グリコピロレート塩 |
CN103690479B (zh) * | 2013-12-04 | 2016-01-20 | 广东嘉博制药有限公司 | 一种格隆溴铵注射液及其制备方法 |
AU2016318594A1 (en) * | 2015-09-11 | 2018-04-26 | Bodor Laboratories, Inc. | Methods and compositions for soft anticholinergic zwitterions |
MY197265A (en) | 2015-09-11 | 2023-06-08 | Bodor Laboratories Inc | Methods and compositions for soft anticholinergic esters |
CN109069390A (zh) * | 2016-04-11 | 2018-12-21 | 苏文生命科学有限公司 | 格隆溴铵的外用喷雾制剂 |
US11759451B2 (en) | 2020-09-15 | 2023-09-19 | City University Of Hong Kong | Therapeutic potential of glycopyrrolate and mexiletine for nervous system injury |
TW202245748A (zh) | 2021-02-05 | 2022-12-01 | 日商三和化學研究所股份有限公司 | 包含吡咯醣・水楊酸鹽之藥品 |
AU2022215452A1 (en) | 2021-02-05 | 2023-07-20 | Sanwa Kagaku Kenkyusho Co., Ltd. | Medicine comprising glycopyrronium salicylate |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5352456A (en) * | 1991-10-10 | 1994-10-04 | Cygnus Therapeutic Systems | Device for administering drug transdermally which provides an initial pulse of drug |
WO2001008681A1 (en) * | 1999-08-02 | 2001-02-08 | First Horizon Pharmaceutical Corporation | Methods of administration of glycopyrrolate compositions |
CN100409847C (zh) * | 1999-11-19 | 2008-08-13 | 美国爱科赛尔制药有限公司 | 乌头属生物碱经皮给药*** |
-
2008
- 2008-06-23 US US12/144,285 patent/US20080317832A1/en not_active Abandoned
- 2008-06-23 EP EP08771753A patent/EP2170305A1/en not_active Withdrawn
- 2008-06-23 MX MX2009014102A patent/MX2009014102A/es not_active Application Discontinuation
- 2008-06-23 JP JP2010513487A patent/JP2010530902A/ja active Pending
- 2008-06-23 AU AU2008268465A patent/AU2008268465A1/en not_active Abandoned
- 2008-06-23 WO PCT/US2008/067908 patent/WO2009002935A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009002935A1 (en) | 2008-12-31 |
JP2010530902A (ja) | 2010-09-16 |
US20080317832A1 (en) | 2008-12-25 |
EP2170305A1 (en) | 2010-04-07 |
AU2008268465A1 (en) | 2008-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009014102A (es) | Sistema de administración transdérmica que comprende glicopirrolato para tratar sialorrea. | |
MX2009005339A (es) | Suspensiones analgesicas de liberacion modificada. | |
PH12015501169A1 (en) | Transdermal delivery system | |
MX2009013574A (es) | Formas de dosificacion solidas o semisolidas de liberacion modificada. | |
MX2009005341A (es) | Sistema terapeutico transdermico para administrar la sustancia activa buprenorfina. | |
CY1118392T1 (el) | Διαταξη διαδερμικης χορηγησεως οπιουχων παρεμποδιζουσα την καταχρηση | |
MX2009000745A (es) | Dispositivos de suministro transmucosa con admision mejorada. | |
TW200631578A (en) | Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury | |
MXPA06012960A (es) | Administracion transdermal de ficotoxinas. | |
WO2007112006A3 (en) | Delivery of highly lipophilic agents via medical devices | |
WO2007109372A3 (en) | Delivery of highly lipophilic agents via medical devices | |
WO2007111885A3 (en) | Delivery of highly lipophilic agents via medical devices | |
WO2009126833A3 (en) | Transdermal oxygen delivery apparatus and method | |
SG184244A1 (en) | Medical devices including medicaments and methods of making and using same | |
TW200722064A (en) | Delivery of highly lipophilic agents via medical devices | |
WO2010042471A3 (en) | Medical devices for delivery of therapeutic agents to body lumens | |
CL2008003507A1 (es) | Composicion farmaceutica que comprende nicotina y un inhibidor de la desensibilizacion del receptor de acetilcolina nicotinico (nachr) opipramol; kit farmaceutico; dispositivo medico; y uso para tratar una enfermedad o trastorno del sistema nervioso central o periferico. | |
MX2007005065A (es) | Forma de dosis de tiempo de retraso de farmacos para la terapia de insomnio. | |
MY183873A (en) | Transdermal therapeutic system for application of an agent | |
CL2009001556A1 (es) | Sistema de administración transdermica de fármacos que comprende una capa que contiene fármaco que comprende una matriz polimérica que contiene estradiol como unico fármaco; método de elaboración; útil para administrar estradiol. | |
MY163809A (en) | Transdermal drug delivery system containing donepezil | |
MX2007005040A (es) | Metodos y composiciones usando moduladores de pde4 para el tratamiento y manejo de lesion al sistema nervioso central. | |
EA201300648A1 (ru) | Трансдермальная терапевтическая система (tts), содержащая ротиготин | |
NZ584190A (en) | Once-a-day replacement transdermal administration of fentanyl | |
MX2010006724A (es) | Regimenes terapeuticos para el tratamiento de desordenes inmunoinflamatorios. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |